HomeNewsBusinessEarningsMangalam Drugs Standalone March 2023 Net Sales at Rs 91.11 crore, down 24.68% Y-o-Y
Trending Topics

Mangalam Drugs Standalone March 2023 Net Sales at Rs 91.11 crore, down 24.68% Y-o-Y

May 31, 2023 / 15:31 IST
Story continues below Advertisement

Reported Standalone quarterly numbers for Mangalam Drugs & Organics are:

Net Sales at Rs 91.11 crore in March 2023 down 24.68% from Rs. 120.96 crore in March 2022.

Story continues below Advertisement

Quarterly Net Loss at Rs. 4.39 crore in March 2023 down 165.54% from Rs. 6.69 crore in March 2022.

EBITDA stands at Rs. 0.54 crore in March 2023 down 94.71% from Rs. 10.20 crore in March 2022.

Mangalam Drugs & Organics
Standalone Quarterly Resultsin Rs. Cr.
Mar'23Dec'22Mar'22
Net Sales/Income from operations90.2763.33119.83
Other Operating Income0.84--1.13
Total Income From Operations91.1163.33120.96
EXPENDITURE
Consumption of Raw Materials55.0367.0175.11
Purchase of Traded Goods0.930.901.22
Increase/Decrease in Stocks14.97-35.787.67
Power & Fuel------
Employees Cost6.299.4311.62
Depreciation2.752.882.69
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses13.6515.3015.15
P/L Before Other Inc. , Int., Excpt. Items & Tax-2.513.597.51
Other Income0.290.13--
P/L Before Int., Excpt. Items & Tax-2.213.727.51
Interest3.433.222.53
P/L Before Exceptional Items & Tax-5.650.504.98
Exceptional Items------
P/L Before Tax-5.650.504.98
Tax-1.260.08-1.71
P/L After Tax from Ordinary Activities-4.390.436.69
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period-4.390.436.69
Equity Share Capital15.8315.8315.83
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS-2.770.274.23
Diluted EPS-2.770.274.23
EPS After Extra Ordinary
Basic EPS-2.770.274.23
Diluted EPS-2.770.274.23
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited